131 related articles for article (PubMed ID: 17652890)
21. Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG.
Niwano S; Sasaki T; Kurokawa S; Kiryu M; Fukaya H; Hatakeyama Y; Niwano H; Fujiki A; Izumi T
Circ J; 2009 Jul; 73(7):1210-8. PubMed ID: 19436116
[TBL] [Abstract][Full Text] [Related]
22. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
[TBL] [Abstract][Full Text] [Related]
23. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
[TBL] [Abstract][Full Text] [Related]
24. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Watanabe N; Asano T; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2010 May; 55(5):511-7. PubMed ID: 20164787
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological conversion of atrial fibrillation in the patients of Graves' disease.
Kunii Y; Uruno T; Matsumoto M; Mukasa K; Noh J; Ito K; Akaishi M; Hori S; Nakazawa H
Tokai J Exp Clin Med; 2012 Dec; 37(4):107-12. PubMed ID: 23238902
[TBL] [Abstract][Full Text] [Related]
27. A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.
Perelman MS; McKenna WJ; Rowland E; Krikler DM
Br Heart J; 1987 Oct; 58(4):339-44. PubMed ID: 3499925
[TBL] [Abstract][Full Text] [Related]
28. Bepridil prevents paroxysmal atrial fibrillation by a class III antiarrhythmic drug effect.
Yoshida T; Niwano S; Inuo K; Saito J; Kojima J; Ikeda-Murakami K; Hara H; Izumi T
Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):314-7. PubMed ID: 12687836
[TBL] [Abstract][Full Text] [Related]
29. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
[TBL] [Abstract][Full Text] [Related]
30. [Rotundium in the treatment of atrial fibrillation].
Wang DJ; Mao HY; Lei M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Aug; 13(8):455-7, 451. PubMed ID: 8111194
[TBL] [Abstract][Full Text] [Related]
31. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns HJ; Jensen SM; Svernhage E; Vallin H; Swedberg K
Pacing Clin Electrophysiol; 1998 May; 21(5):1044-57. PubMed ID: 9604236
[TBL] [Abstract][Full Text] [Related]
32. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation.
Miyazaki S; Kuwahara T; Kobori A; Takahashi Y; Takei A; Sato A; Isobe M; Takahashi A
Europace; 2009 Dec; 11(12):1620-3. PubMed ID: 19910313
[TBL] [Abstract][Full Text] [Related]
34. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
35. Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.
Nakatani Y; Sakamoto T; Nishida K; Kataoka N; Yamaguchi Y; Sakabe M; Fujiki A; Mizumaki K; Inoue H
J Cardiol; 2015 Nov; 66(5):445-50. PubMed ID: 26162947
[TBL] [Abstract][Full Text] [Related]
36. Opposing effects of bepridil on ventricular repolarization in humans. Inhomogeneous prolongation of the action potential duration vs flattening of its restitution kinetics.
Osaka T; Yokoyama E; Kushiyama Y; Hasebe H; Kuroda Y; Suzuki T; Kodama I
Circ J; 2009 Sep; 73(9):1612-8. PubMed ID: 19609043
[TBL] [Abstract][Full Text] [Related]
37. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
Madan N; Saksena S
Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
[TBL] [Abstract][Full Text] [Related]
38. Importance of morphological changes in T-U waves during bepridil therapy as a predictor of ventricular arrhythmic event.
Kurokawa S; Niwano S; Kiryu M; Murakami M; Ishikawa S; Yumoto Y; Moriguchi M; Niwano H; Kosukegawa T; Izumi T
Circ J; 2010 May; 74(5):876-84. PubMed ID: 20354335
[TBL] [Abstract][Full Text] [Related]
39. Impact of medical treatment on long-term results after surgical ablation of atrial fibrillation in cardiac surgical patients.
Feyrer R; Ballazhi F; Seitz T; Weyand M; Harig F
Ann Thorac Cardiovasc Surg; 2014; 20(3):207-12. PubMed ID: 23558224
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
Singh BN; Mody FV; Lopez B; Sarma JS
Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
